Elv stock price has shown resilience this week

ELV stock price has shown resilience this week, trading around $113.05, supported by healthcare demand stability. MACD patterns indicate a likely near-term breakout if volume sustains. Elevance Health, Inc. (NYSE:ELV) is not on our list of 30 Most Popular Stocks Among Hedge Funds . As per our database, 67 hedge fund portfolios held Elevance Health, Inc. (NYSE:ELV) at the end of the second quarter, which was 75 in the previous quarter. In Q2 2025, Elevance Health, Inc. (NYSE:ELV) reported $49.4 billion of operating revenue , an increase of 14% year-over-year. While we acknowledge the potential of Elevance Health, Inc. (NYSE:ELV) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock . These are just a few reasons Elevance Health is a high-quality business worth owning. After the recent drawdown, the stock trades at 8.4× forward P/E (or $308.66 per share). Is now the right time to buy? See for yourself in our comprehensive research report, it’s free . As the session progresses, ELV stock price holds around $112.95, maintaining gains from early in the week. Higher earnings per share guidance could act as a catalyst for continued upward momentum.